ROG
Rogers Corp.

453
Loading...
Loading...
News
all
press releases
Strength Seen in Ouster (OUST): Can Its 13.4% Jump Turn into More Strength?
Ouster (OUST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·15d ago
News Placeholder
More News
News Placeholder
Rogers Corp. (ROG) Q2 Earnings Lag Estimates
Rogers Corp. (ROG) delivered earnings and revenue surprises of -32.00% and +2.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Sarepta stock falls after Elevidys fails to get backing by EU regulators
Investing.com -- Sarepta Therapeutics Inc. (NASDAQ:SRPT) stock declined 13% Friday after European regulators recommended against approving Elevidys, the company’s gene therapy for Duchenne muscular dystrophy.
investing.com·2mo ago
News Placeholder
TTM (TTMI) Surges 5.4%: Is This an Indication of Further Gains?
TTM (TTMI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·2mo ago
News Placeholder
European pharmaceutical shares edge lower after Trump threatens 200% drug tariff
Investing.com - Shares of European drugmakers slipped on Wednesday after U.S. President Donald Trump said that tariffs of up to 200% on pharmaceutical imports could be coming "very soon."
investing.com·3mo ago
News Placeholder
Deutsche Bank bearish on European pharma stocks into Q2 amid political headwinds
Investing.com -- Deutsche Bank has made several rating and target price adjustments across the European pharmaceuticals space ahead of second-quarter earnings, flagging continued weakness in the sector and potential opportunities in select names.
investing.com·3mo ago
News Placeholder
Roche shares Fall 2% after fatalities halt Elevidys dosing in key patient group
investing.com·4mo ago
News Placeholder
Not just Nvidia: These lesser-known names are also up 5%+ on AI optimism
At the start of each month, our AI refreshes each strategy with up to 20 stock picks. These selections are based on a blend of more than 150 well-established financial models.
investing.com·4mo ago
News Placeholder
HSBC cuts biotech stocks: Eli Lilly lowered to Reduce
Investing.com -- HSBC downgraded several major biotech names this week, citing macroeconomic sensitivities, tariff risks, and growing pressure from regulatory changes. Most notably, the bank downgraded Lilly to Reduce from Buy.
investing.com·5mo ago
News Placeholder
European stocks trade in cautious manner amid economic uncertainty
Investors bought a net $11 billion in European equity funds and $3.6 billion in Asian equity funds in the week to April 16, while U.S. equity funds saw an outflow of $10.6 billion, according to LSEG Lipper data.
investing.com·6mo ago

Latest ROG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.